Waverley Pharma Inc V.WAVE

Healthcare Biotechnology

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.

TSXV:WAVE - Post by User

Waverley Pharma Inc > More facts than feelings

<< Previous

Bullboard Posts

Next >>

Comment by NEMOMEIMPUNEon Dec 03, 2020 2:36pm

162 Views

Post# 32030027

RE:More facts than feelings

Time to do some thinking, before events runs in front of us.

Taking “free to buy” shares as a fact. The number should be 13.000.000 shares (the rest is firmly in the hands of the management). That amounts to CAD: 1.820.000 (CAD: 0,14/ share).

When (if) things turn in the right direction during the next two to three month. How many investors will be lucky to get in on current levels and in sufficient amount of shares.

I am astound that so many still think they can enter in about a month, and hope they scoop up large piles of shares on these levels.

One can only say….Good Luck !!

<< Previous

Bullboard Posts

Next >>

Hillcrest and Ocean Batteries expand marine electrification collaboration